Dynamk Capital
VC
INVESTOR TYPE
Active
STATUS
5
PROFESSIONALS
4
INVESTMENTS
3
PORTFOLIO
1
EXITS
Description
Dynamk Capital is a growth equity and venture capital firm investing in life science companies. Dynamk's investment strategy is centered on Life Science Industrials: companies developing technologies, tools, and services that enable the full biopharma continuum across discovery, development, and manufacturing of therapeutics. Dynamk is headquartered in New York City.
Website
Investor Status
Actively Seeking New Investments
Year Founded
2015
Primary Investor Type
Venture Capital
Primary Office
- 30 Wall Street
- 12th Floor
- New York, NY 10005
- United States
Dynamk Capital Investments (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| CellFE | 16-Jan-2020 | Seed Round | 00.00 | Pharmaceuticals | Startup | 00000000 0000000 |
| 0000000000 | 06-Aug-2019 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue | 00000000 0000000 |
| Flodesign Sonics | 11-Jan-2018 | Later Stage VC | Discovery Tools (Healthcare) | Generating Revenue | 00000000 0000000 | |
| Envisagenics | 28-Nov-2017 | Seed Round | 00.00 | Biotechnology | Generating Revenue | 00000000 0000000 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Dynamk Capital’s full profile, request a free trial.
Dynamk Capital Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000000 000000 | 10-Oct-2019 | 000000000000000000 | Completed |
|
Dynamk Capital Team (5)
Dynamk Capital Co-Investors (11)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| Dolby Family Ventures | 1 | 0 | |
| SV Angel | 0 | 0 | |
| Third Kind Venture Capital | 0 | 0 | |
| Topspin Partners | 0 | 0 | |
| Vanedge Capital | 0 | 0 |